RSS Worldwide Bio News

  • Pfizer Seeks Patent Covering a Friedreich’s Ataxia Therapy That Resverlogix Has Already Developed
    This post was originally published on this site Pfizer is seeking a European patent on a family of compounds that can treat Friedreich’s ataxia by increasing levels of the frataxin protein that is lacking in the disease. It noted in its patent application that Resverlogix has already developed a therapy called apabetalone (RVX-208) that is based on the […]
  • PML Found in Ocrevus-Treated Patient Who Had Used Tysabri for 3 Previous Years
    This post was originally published on this site A multiple sclerosis (MS) patient treated in Germany with Ocrevus (ocrelizumab) has developed the dreaded brain infection progressive multifocal leukoencephalopathy (PML). But it is not clear whether the recently approved Genentech/Roche-developed treatment is the cause. The patient took the last dose of a three-year course of Tysabri (natalizumab) in February. Tysabri is a […]
  • Cure SMA Awards OSU’s Stephen J. Kolb $75,000 Grant to Study Motor Neuron Pathology in SMA Piglets
    This post was originally published on this site Cure SMA has awarded a $75,000 basic research grant to Dr. Stephen J. Kolb of Ohio State University (OSU) for a project that seeks a deeper understanding of motor neuron pathology in spinal muscular atrophy (SMA). The project, “Arrested Development or Neurodegeneration? An approach to understand developmental motor […]
  • Electric Stimulation as a Drug-Free Option for Managing MS Pain
    This post was originally published on this site One of the biggest ongoing threads we have in the forum I help admin revolves around the subject of pain. We all know how pain can be disabling, or if not disabling, still influential over our moods, our ability to sleep, our energy levels, even the decisions […]
  • Fampyra Granted Standard Approval in Europe as Trial Results Support Effectiveness
    This post was originally published on this site Fampyra (prolonged-release fampridine tablets) — sold in the U.S. as Ampyra (dalfampridine) — has now been granted standard marketing authorization in Europe. The approval was based on the results of a Biogen-sponsored Phase 3 clinical trial confirming the drug’s safety and efficacy in improving walking in patients […]
  • Teva Pharmaceuticals Europe Launches ‘Life Moments with MS’ to Mark May 31, World MS Day
    This post was originally published on this site May 31 is World MS Day. In its honor, Teva Pharmaceuticals Europe has launched “Life Moments with MS” — a social media campaign to raise awareness about the challenges people with multiple sclerosis (MS) face every day. Teva’s campaign, which uses the hashtag #LifeMomentswithMS, also includes educational resources on […]
  • 7 Things Only Women With Endometriosis Will Understand
    This post was originally published on this site Endometriosis is a condition that most women have heard of, yet few truly understand the implications of the disease. It often shrugged off, dismissed and belittled with women spending years trying to get diagnosed and treated. Unsolicited advice seems to be part of the package when it comes […]
  • Preparing for Trips Outside the Home When You Have Children With SMA
    This post was originally published on this site Leaving the home when you have children with SMA can be challenging. There are many factors to take into consideration to ensure the comfort and safety of your child. MORE: Seven support care areas that can help with SMA. Dany is a mom who understands this all too well. […]
  • Multiple Sclerosis News Today Named One of Healthline.com’s ‘Best MS Blogs of the Year’
    This post was originally published on this site Multiple Sclerosis News Today is proud to announce that we’ve been named one of healthline.com’s best multiple sclerosis blogs of the year. We’d like to thank healthline.com for acknowledging our efforts, and we’d especially like to thank our columnists for their incredible dedication, courage, service and passion. Laura Kolaczkowski Laura is […]
  • Women Worldwide Call for More Endometriosis Research and Efforts to Find a Cure
    This post was originally published on this site Endometriosis affects about 176 million women worldwide, yet research into its causes and a potential cure are significantly lacking. To reverse that trend, a new effort led by the University of Edinburgh’s Medical Research Centres (MRC) for Reproductive Health and the nonprofit James Lind Alliance has identified 10 priority areas for […]